Product Description
Leading Justice is a full-service marketing company working with law firms on a cash-buy basis to sign up fully qualified, fraud-free Philips CPAP injury cases. Here at Leading Justice, we can customize your firm’s CPAP, BiPAP and ventilator advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of Philips CPAP recall advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, which means any data we generate that doesn’t qualify for the target campaign is evaluated to determine whether it qualifies for another type of claim. By using advanced approaches to target contacts specifically related to the Philips CPAP recall and side effects like cancer and respiratory problems, Leading Justice will increase your firm’s Philips CPAP injury caseload. If you are interested in helping victims of Philips CPAP side effects and complications, our direct advertising strategies and broad consumer reach at Leading Justice give you the competitive edge and confidence you need to allocate your full budget, knowing that your money is being used in the best way possible.
Each law firm we work with at Leading Justice plays a crucial role in determining how we categorize claims as qualified or not. And while our experience working with plaintiff law firms allows us to recognize a great case when we see one, we will customize our Philips CPAP recall intake specifications to the exact criteria you are seeking. So, if your firm has specific Philips CPAP qualifying case criteria you want us to use, we can train our intake specialists to apply the criteria to each phone call and email they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of Philips CPAP injury data with no chance of fraud.
Philips CPAP, BiPAP and Ventilator Litigation
Obstructive sleep apnea is a serious condition affecting millions of Americans, and the first line of treatment for this condition is the use of a CPAP or BiPAP machine, both of which are designed to keep the airways open during sleep and improve users’ respiration and sleep quality. CPAP and BiPAP machines and ventilators used to mechanically control or assist patient breathing can offer life-saving treatment for people with obstructive sleep apnea or for those who can’t breathe properly or who are unable to breathe on their own at all. However, in certain CPAP, BiPAP and ventilator devices manufactured by Philips Respironics, the polyester-based polyurethane (PE-PUR) sound abatement foam used to diminish sound and vibration inside the devices may break down over time, which could pose a serious health risk for users who ingest or inhale foam debris or inhale chemicals off-gassed from the foam.
In June 2021, Philips Respironics announced a massive recall of 3.5 million CPAP (continuous positive airway pressure) and BiPAP (bi-level positive airway pressure) machines and mechanical ventilators used to provide breathing assistance for people with obstructive sleep apnea and other serious medical conditions. According to a safety communication issued by the FDA, the PE-PUR foam used in the recalled devices may degrade into particles which may enter the device’s air pathway and be inhaled or swallowed, or release certain chemicals into the device’s air pathway, which may be inhaled. “These issues can result in serious injury, which can be life-threatening, cause permanent impairment, and require medical intervention to prevent permanent damage,” the FDA warns. As a result of problems with the sound abatement foam used in the recalled Philips CPAP, BiPAP and ventilator devices, former users are now filing lawsuits seeking compensation from Philips Respironics for injuries ranging from respiratory tract problems and inflammatory responses to cancer.